The company expired its plan on September 8, 2025.
Gan & Lee Pharmaceuticals.'s Equity Buyback announced on September 6, 2024, has expired with 3,540,021 shares, representing 0.6% for CNY 150.07 million
Published on 09/02/2025 - Modified on 09/07/2025

















